A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes (NCT07112339)
EFFectiveness of Once-weekly Insulin ICodec Versus Once-daily Basal Insulin Analogues in an Insulin-naïve Type 2 diabEtes Population in Real-world cliNical pracTice- The EFFICIENT Pragmatic Study Effectiveness of Insulin Icodec in Real-world Clinical Practice
🩺 Plain-English Summary (8th-Grade Level)
This study compares insulin icodec, taken once a week, with other basal insulins, taken once a day, in people with type 2 diabetes.The purpose of this study is to see how well the approved injectable weekly insulin icodec maintains blood sugar levels when compared to approved and available daily injectable basal insulins in people with type 2 diabetes. The participants will either be prescribed weekly insulin icodec or a daily basal insulin (insulin glargine, insulin detemir or insulin degludec) based on current standards for the treatment of type 2 diabetes. The study will last for about 13 months.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (4 items) and avoid the listed exclusions (6 items).
Location: Centricity Research Calgary Endocrinology — Calgary, Alberta
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Known or suspected hypersensitivity to study intervention(s) or related products.
- Previous participation in this study. Participation is defined as signed informed consent.
- Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using adequate contraceptive method.
- Participation (i.e., received any study intervention) in any interventional clinical study within 90 days before screening.
- Any disorder which in the investigator's opinion might jeopardize participant's safety.
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (75 Sites)
Showing the first 25 of 75 sites.
- Centricity Research Calgary Endocrinology — Calgary, Alberta
- Alta Clinical Research at Hermitage Medicentre — Edmonton, Alberta
- Fraser Clinical Trials Inc. — New Westminster, British Columbia
- Winnipeg Clinic — Winnipeg, Manitoba
- G.A. Research Associates Ltd. — Moncton, New Brunswick
- Centricity Research Brampton Endocrinology — Brampton, Ontario
- Centricity Clinical Research Burlington — Burlington, Ontario
- Centricity Research Vaughn Endocrinology — Concord, Ontario
- Medical Trust Clinics, Inc. — Courtice, Ontario
- Centricity Research Etobicoke Endocrinology — Etobicoke, Ontario
- Janik Research — Greater Sudbury, Ontario
- Hamilton Medical Research Group — Hamilton, Ontario
- St. Josephs Health Care — London, Ontario
- Western Univ. Cnt for Studies in Fam Med — London, Ontario
- Malton Medical Clinic — Mississauga, Ontario
- Centricity Research Ottawa LMC — Nepean, Ontario
- The Ottawa Hospital_Riverside — Ottawa, Ontario
- Bluewater Clin Res Group Inc — Sarnia, Ontario
- Sewa Ram Singal Medicine Professional Corp — Toronto, Ontario
- Centricity Research Toronto — Toronto, Ontario
- Centricity Research Toronto Manna Multispec — Toronto, Ontario
- Diex Recherche Joliette — Joliette, Quebec
- Alpha Recherche Clinique - Clinique de Levis — Lévis, Quebec
- Centricity Research Mirabel — Mirabel, Quebec
- Centre hospitalier de l'Universite de Montreal — Montreal, Quebec
📞 Contact the Study Coordinator
Phone: (866) 867-7178
Email: clinicaltrials@novonordisk.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Diabetes Mellitus, Type 2
- Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland — Nuuk, Sermersooq
- Project Dulce for Arab Americans With Type 2 Diabetes — El Cajon, California
- Sleep for Health Study on the Effects of Cognitive Behavioral Therapy for Insomnia on Diabetes Risk — Portland, Oregon
- Integrating Abbott Point-of-Care Technologies and the Community Scientist Model to Support HbA1c Testing Per ADA — Santa Barbara, California
- Diabetes Discharge Transitional CGM Study (DDT-CGM) — Logan, Utah
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes — Lancaster, California
Explore by condition: All Diabetes Mellitus, Type 2 clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.